Breaking AI & Tech News Analyzed

The End of LIV Golf as We Know It Confirmation that Saudi Arabia's Public Investment Fund will cease funding the LIV Golf tour will have huge ramifications for the future of the tour itself, the players, and across golf's traditional heartlands. Where does PIF's withdrawal leave them all? Will 2026 be LIV Golf's Final Year? Certainly in its present form, as a 14-event entity worth $30m per tournament. LIV was entirely reliant on Saudi Arabian money, to the tune of more than $5bn since 2021. The cash burn rate, albeit slowed down recently, has always been unsustainable. It is feasible that Scott O'Neil, LIV's chief executive, will find backers for the business at a level which means it can be prolonged in some way. He has already attracted marquee sponsors and overseen significant revenue growth. The Impact on Players Quite the range. There are marquee names: Bryson DeChambeau, Jon Rahm, Cameron Smith, Tyrrell Hatton, Lee Westwood, Dustin Johnson, Ian Poulter and Phil Mickelson among them. There are younger, emerging talents such as José Luis Ballester. Anthony Kim's return from oblivion has been a fascinating tale. What Are Their Options? There is a misconception that LIV golfers will automatically want to beat a path back to the PGA Tour. Some have lingering, ongoing problems with the nature or the style of PGA Tour life. Many have also dedicated a lot of effort and time into making LIV team franchises work. Will the PGA Tour Be Sympathetic? Yes and no. The PGA Tour can flex muscles and portray victory over the rebels if big names shuffle back to its domain. The PGA Tour is also now in a stronger negotiating position than ever in respect of what terms players may have to accept to return. The DP World Tour's Position The long-time theory that the former European Tour should form a business partnership with Saudi Arabia will end as the kingdom abruptly exits male elite golf. A deal with LIV? Not totally out of the question but very difficult to envisage given the strategic alliance that exists between the DP World and PGA Tours. How Should Other Sports View PIF's Withdrawal? With extreme caution. Saudi Arabia did not simply sponsor or assist the LIV Tour. Instead, the circuit was entirely reliant on Public Investment Fund backing. It is unclear to what extent the Iran war has triggered a change in approach from the PIF – it was possible sport was being marginalised anyway – but recent weeks have illustrated the danger of being so beholden to a regime answerable to no one.

FDA Clearance Marks a Milestone for BioticsAI's Ultrasound AI CopilotRobhy Bustami, co‑founder and CEO of BioticsAI, announced that the company obtained FDA approval in January 2026, unlocking the ability to launch its fetal‑abnormality detection system in clinical settings.From Scrappy Prototype to Regulatory SuccessThe team built a functional prototype for under $100,000, an unusually low cost for a medical‑device startup. That early version helped them win TechCrunch Startup Battlefield 2023, providing visibility and credibility that accelerated investor interest.Prototype cost: $100kTechCrunch Battlefield win: 2023FDA approval received: January 2026Financial and Timeline Metrics Behind the ClearanceWhile the article does not disclose full fundraising numbers, the rapid prototype and battlefield win suggest a capital‑efficient path. Early regulatory engagement—pre‑submission meetings with the FDA— reduced uncertainty and compressed the typical multi‑year approval timeline.Early regulator meetings: pre‑submission phaseTypical FDA device timeline: 18‑36 months (compressed by early alignment)Why FDA Approval Shifts the AI‑Healthcare LandscapeGaining clearance validates the technical approach and signals to hospitals that the product meets rigorous safety standards. It also demonstrates a repeatable model for other AI‑driven diagnostics, encouraging more founders to embed regulatory strategy from day one.Creates a trusted entry point for hospital adoptionSets a precedent for AI‑based fetal imaging toolsHighlights the need for cross‑functional teams (engineers, clinicians, regulators)Looking Ahead: Expansion Beyond ObstetricsWith the FDA hurdle cleared, BioticsAI plans to deploy its technology across obstetric units and later broaden into other reproductive‑health applications. The founder emphasizes continued data collection, partnership growth, and potential international regulatory filings as the next growth levers.Phase 1: Hospital rollout in obstetrics (2026‑2027)Phase 2: Expansion into broader reproductive health diagnostics (2028+)Long‑term goal: Global market penetration with localized regulatory approvals

Lead: The Evening's High‑Stakes DerbyAt 8 pm BST the City Ground becomes the stage for a rare showdown between two neighbouring English clubs in a European semi‑final. The atmosphere is described as "absolutely colossal" as fans anticipate a match that blends cup‑final intensity with continental ambition.Event Details: Form, History, and Kick‑offKick‑off: 20:00 BSTNottingham Forest: 16th in the Premier League, recent surge in form after a relegation‑battle narrative.Aston Villa: 5th in the Premier League, historically the stronger side but currently struggling with spotty performances.Historical backdrop: Forest lifted the UEFA Cup in 1979 and 1980; Villa won it in 1982, adding a nostalgic layer to the encounter.Data Snapshot: League Positions and Recent ResultsWhile no specific match‑day statistics are available yet, the league standings provide a clear contrast:Forest: 16th place, points tally hovering just above the relegation zone.Villa: 5th place, within striking distance of a top‑four finish.These positions suggest a classic underdog versus favorite dynamic, amplified by recent form trends.Impact: Regional Pride and European AmbitionsThe fixture is more than a semi‑final; it is a clash of regional identity. Success for either side could:Boost the winning club’s European credibility and attract higher‑profile players.Reignite local rivalries, influencing ticket sales and fan engagement across the Midlands.Potentially affect Premier League momentum, with a win offering a psychological edge in the domestic race.Looking Ahead: Scenarios for the Semi‑FinalAnalysts foresee three primary outcomes:Forest edge a narrow win: A 1‑0 or 2‑0 advantage would give them a realistic chance to reach the final, leveraging home support.Villa dominate: A two‑goal margin could see them control the tie, making the second leg a formality.Dead‑heat: A draw would set up a tense return leg at Villa Park, where the higher‑ranked side might rely on their league quality.Regardless of the result, the tie promises to shape the narrative of English clubs in Europe for the remainder of the season.

The Journey from Prototype to ClearanceBuilding a medical device is fundamentally different from standard software development. This week on Build Mode, host Isabelle Johannessen sat down with Robhy Bustami, co-founder and CEO of BioticsAI, to discuss the arduous path from a $100,000 prototype to FDA clearance. Bustami, a Startup Battlefield winner, detailed how his team is building an AI copilot for ultrasound designed to detect fetal abnormalities. The conversation revealed that the traditional startup mantra of 'move fast and break things' is obsolete in the medical sector, replaced by a necessity for extreme precision and coordination.Market Validation and Resource AllocationThe episode provides a strategic look at the 'data' driving medtech success. BioticsAI's recognition as a Startup Battlefield winner serves as a key validation of their technology's potential. However, Bustami emphasized that the primary data point for founders is not just market traction, but the successful navigation of complex regulatory pathways. This requires a significant reallocation of resources—shifting focus from rapid feature deployment to ensuring safety, reliability, and compliance with FDA standards.Shifting the MedTech CultureThe core impact of this discussion lies in the cultural shift it highlights for the industry. As timelines for FDA approval remain uncertain, the ability to maintain team morale and investor confidence becomes a critical operational metric. Bustami noted that building in a regulated industry requires a foundation of trust rather than speed. This signals a broader trend where medtech startups must balance the pressure of hyper-growth with the ethical and legal responsibilities of patient safety.The Future of AI in Healthcare RegulationLooking ahead, the medtech landscape will likely see a consolidation of companies that prioritize long-term compliance over short-term hype. As more AI copilots enter the market, the winners will be those founders who master the art of 'slow and steady' innovation. The next wave of medical breakthroughs will depend not just on algorithmic superiority, but on the ability to build sustainable organizations capable of weathering the regulatory storm.

The Challenges of FDA Approval Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain. Lessons from BioticsAI This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building an AI copilot for ultrasound to help detect fetal abnormalities. From a $100,000 prototype to FDA clearance, Bustami shares what it actually takes to build in one of the most regulated industries in the world. Building a Medtech Startup In this episode, they break down what it really looks like to build a medtech startup, including where you can’t “move fast and break things” and that every milestone takes time, coordination, and trust. Key Takeaways Team motivation is crucial during the long FDA approval process Finding the right investors is essential for medtech startups Adaptability is key when dealing with uncertain timelines Future Outlook As the medtech industry continues to evolve, startups like BioticsAI will play a critical role in shaping the future of healthcare technology. With the right approach and mindset, these companies can overcome the challenges of FDA approval and make a lasting impact.

The Musical Collaboration Cellist Paul Watkins and pianist Alessio Bax bring their shared musical impulse to Beethoven's cello sonatas, delivering an unflaggingly eloquent performance. Watkins, a veteran cellist of the Nash Ensemble and the Emerson Quartet, has immersed himself in almost all of Beethoven's chamber music, and this experience shines through in their collaboration. The Sonatas The five sonatas span Beethoven's composing life, from the early sonatas that break new ground in writing for cello and keyboard as equal duet partners, to the later sonatas that harness Watkins's full powers of expression. The expansive third sonata, Op 69, centers on a perky middle movement akin to a symphonic scherzo, while the final pair of sonatas showcase the duo's ability to handle complex passages with tightly controlled restraint. The Performance Watkins and Bax's performance is marked by a light, crisp touch, particularly in the earlier sonatas. The slow, serious introductions lead into extended movements showcasing the virtuosity of the pianist, to which Bax rises with ease. The duo handles the closing passages of the fifth sonata with restraint, then gently clears the air with the introduction to the wrangly little fugue of the finale. The Verdict Overall, Watkins and Bax's performance of Beethoven's cello sonatas is beautifully done, with a deep understanding of the music and a shared impulse to deliver eloquence. The album is available to listen on Apple Music and Spotify.

The Emotional Departure of a Tottenham CaptainBethany England, the captain of Tottenham Hotspur Women, has confirmed her departure from the club at the end of the current season in an emotional video message shared with fans. The 31-year-old striker, who has been instrumental to the team's success during her three and a half years at the club, expressed her deep appreciation for the support she received during her time at Tottenham.Strategic Squad Evolution at TottenhamThe club's decision not to renew England's contract is part of a broader strategy to evolve the squad with younger players. Multiple sources have emphasized that Tottenham is expected to be aggressive and highly ambitious in the upcoming transfer market. This move comes alongside several other confirmed summer exits, including Amy James-Turner, Luana Bühler, Charlotte Grant, Josefine Rybrink, and Kit Graham, indicating a significant transformation of the squad.England's Remarkable Statistical LegacyDuring her time in the Women's Super League, England has established herself as one of the competition's most prolific scorers. She is the WSL's second-highest goalscorer in the division's 15-year history, with 89 goals—eight behind record holder Vivianne Miedema. In March 2026, she became only the seventh player to reach 200 WSL appearances, a testament to her consistency and quality at the highest level of women's football in England.Impact on Tottenham and Women's FootballEngland's departure represents a significant loss for Tottenham, both on and off the pitch. During her tenure, she helped the team reach the 2024 Women's FA Cup final and was crucial in steering the team clear of relegation during her first six months after arriving from Chelsea. Her leadership has been described as having "shaped a defining era" in Tottenham women's football history, driving up standards, professionalism, and desire within the squad.Future Outlook for England and TottenhamAs a free agent with an impressive track record, England is likely to be highly sought after by other clubs. Her experience, goal-scoring prowess, and leadership qualities make her an attractive addition to any team. Meanwhile, Tottenham appears set on a summer recruitment drive to rebuild their squad with younger talent, signaling a new direction for the club as they aim to compete at the highest level of women's football in the coming seasons.

The Lead When USA Rugby updated its eligibility requirements in February to ban trans women from competing, many players and fans were outraged. The ban has sparked a movement among US women's rugby players to fight for inclusivity and find ways to work around the policy. The Event Details The trans-exclusionary policy, which aligns with recent updates from other national governing bodies in sports, has been met with resistance from the rugby community. Dozens of teams have posted messages on social media announcing their intention not to play without their trans teammates, and a fund was started to support affected players who want to pursue legal action. The Data Analysis No specific data was provided in the article, but it is clear that the ban has had a significant impact on the US women's rugby community. The sport is known for being one of the queerest and most gender-inclusive, with the guiding principle being "every body is a rugby body". The Impact Analysis The ban has created a divide in the rugby community, with some teams and players pushing for inclusivity and others feeling forced to comply with the policy. The new policy has also created a third "open" division, allowing people of any sex or gender designation to play, but advocates say this is not a fair or workable solution. The Prediction As the fight for inclusivity continues, it is likely that the US women's rugby community will find creative ways to work around the ban. The momentum behind teams moving to the open division together could be a groundbreaking model for other sports to follow. Ultimately, the outcome will depend on the actions of USA Rugby and the rugby community as a whole.

The LeadDespite US Secretary of Defense boasting of rapid military success against Iran, the Pentagon has suffered significant losses with military equipment worth between $2.3bn and $2.8bn destroyed in the ongoing conflict. The most notable incidents include the destruction of a $700m radar aircraft and multiple missile defense systems.The Event DetailsThe conflict began on February 28, with US officials initially claiming rapid success. However, Iran's response has been more effective than anticipated. On March 26, US Secretary of Defense Pete Hegseth made a bold claim at a televised Cabinet meeting: "Never in recorded history has a nation's military been so quickly and so effectively neutralised."The very next day, Iran retaliated by firing missiles and drones that struck a US base in Saudi Arabia, wounding several US soldiers and destroying a $700m E-3 AWACS/E7 radar surveillance aircraft. This airborne command center, capable of detecting aircraft and missiles hundreds of kilometers away, was destroyed at Prince Sultan airbase in eastern Saudi Arabia.Additional losses include at least one THAAD missile defense radar system worth between $485m and $970m, and three F-15 jets lost to friendly fire in Kuwait in early March.The Data AnalysisThe Washington, DC-based Center for Strategic and International Studies (CSIS) has conducted the first detailed tabulation of US military losses in the conflict. Senior adviser Mark Cancian, a retired US Marine colonel with over three decades of military experience, calculated the losses at between $2.3bn and $2.8bn.Notably, this estimate does not include losses incurred at US bases in the region or specialized equipment and naval assets. Cancian noted that assessing damages to bases has been challenging due to US government restrictions on satellite imagery from Planet Labs since February 28.The CSIS analysis reveals that while the US has achieved some operational victories, the financial cost has been substantial. The most expensive single loss was the E-3 AWACS/E7 aircraft at $700m, followed by the THAAD radar systems.The Impact AnalysisThe losses have significant strategic implications for US military posture in the Middle East. Omar Ashour, professor of security and military studies at the Doha Institute for Graduate Studies, suggests that while the US has disclosed some figures, it cannot afford full transparency for political reasons."At this point, I don't think the Trump administration would want to be looking like losing equipment [and] personnel," Ashour told Al Jazeera, adding that there might be a "price" to pay "at the [midterm] elections in November."The conflict has also affected US relations with Gulf nations. Iran's decision to strike Gulf nations, not just US bases, backfired by driving them closer to the United States, according to Cancian. Additionally, the US failure to keep the Strait of Hormuz open has been a humbling reminder of naval unpreparedness.Despite these losses, Ashour notes that Iran has also suffered severe damage to its military. The US-Israeli operation has degraded Iran's conventional military architecture but has not eliminated its missiles, munitions, and drones.The PredictionLooking ahead, experts suggest that the US may need to reassess its strategy in the region. The current US troop deployment constitutes less than a tenth of the force used to invade Iraq in 2003, and the US lacks the number of aircraft carriers previously deployed.Cancian, reflecting on his military experience, noted that the US has been planning for potential conflicts with Iran for 45 years, including amphibious operations to capture Qeshm Island. However, "when the US launched the current war, they didn't have the forces in place."The conflict may ultimately follow historical patterns where operational victories do not translate to strategic success. As Ashour points out, "In Vietnam, they did a series of operational victories. In Afghanistan, they did. But then [they suffered] the strategic loss in the end."With midterm elections approaching, the Trump administration faces pressure to demonstrate progress toward its proclaimed goals of regime change and denuclearizing Iran, even as the financial and strategic costs continue to mount.